北京大学学报(医学版) ›› 2023, Vol. 55 ›› Issue (5): 886-892. doi: 10.19723/j.issn.1671-167X.2023.05.017

• 论著 • 上一篇    下一篇

孕早期单纯甲状腺过氧化物酶抗体阳性与胎儿生长的关联

徐金辉1,韩娜2,苏涛2,林力孜3,计岳龙1,周双1,包鹤龄1,刘峥1,罗树生1,徐相蓉1,王海俊1,*()   

  1. 1. 北京大学公共卫生学院妇幼卫生学系, 北京 100191
    2. 北京市通州区妇幼保健院, 北京 101100
    3. 中山大学公共卫生学院劳动卫生与环境卫生学系, 广州 510080
  • 收稿日期:2021-02-23 出版日期:2023-10-18 发布日期:2023-10-09
  • 通讯作者: 王海俊 E-mail:whjun@pku.edu.cn
  • 基金资助:
    国家自然科学基金(92046019);国家自然科学基金(81973053)

Association of maternal isolated thyroid peroxidase antibody positive in the first trimester with fetal growth

Jin-hui XU1,Na HAN2,Tao SU2,Li-zi LIN3,Yue-long JI1,Shuang ZHOU1,He-ling BAO1,Zheng LIU1,Shu-sheng LUO1,Xiang-rong XU1,Hai-jun WANG1,*()   

  1. 1. Department of Maternal and Child Health, School of Public Health, Peking University, Beijing 100191, China
    2. Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101101, China
    3. Department of Occupational and Environmental Health, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China
  • Received:2021-02-23 Online:2023-10-18 Published:2023-10-09
  • Contact: Hai-jun WANG E-mail:whjun@pku.edu.cn
  • Supported by:
    the National Natural Science Foundation of China(92046019);the National Natural Science Foundation of China(81973053)

摘要:

目的: 研究孕早期单纯甲状腺过氧化物酶抗体(thyroid peroxidase antibody, TPOAb)阳性与胎儿生长的关联。方法: 采用出生队列研究设计, 选取末次月经在2016年5月至2019年4月且在北京市通州区妇幼保健院分娩的16 446名单胎孕妇, 按照孕早期甲状腺功能状态分为单纯TPOAb阳性组(n=1 654)和甲状腺功能正常组(n=14 792)。三次超声测量胎儿生长指标由超声科医生在常规产前超声检查时按照统一方法测量得到, 采用基于位置、尺度、形状参数的广义加性模型, 校正胎龄及性别计算超声测量胎儿生长指标Z评分, 胎儿生长结局指标包括预测胎儿体质量、腹围、双顶径(biparietal diameter, BPD)、股骨长和头围的Z评分以及胎儿生长受限。采用广义估计方程分析单纯TPOAb阳性与多次重复测量的胎儿生长结局指标的关联。对广义估计方程分析中有统计学意义的关联结果, 进一步采用广义线性模型分析单纯TPOAb阳性与不同孕周的结局指标之间的关联。结果: 三次超声测量孕周中位数分别为23.6(23.3, 24.1)、30.3(29.7, 30.9)和37.3(37.0, 37.7)周。单纯TPOAb阳性组BPD的Z评分比甲状腺功能正常组高0.057(95%CI: 0.014~0.100, P=0.009)。进一步根据孕周进行分层分析, 结果比较稳定(P<0.05), 与甲状腺功能正常组相比较, 单纯TPOAb阳性组BPD的Z评分在21~25孕周高0.052, 在29~32孕周高0.055, 在36~40孕周高0.068。单纯TPOAb阳性组与甲状腺功能正常组预测胎儿体质量、腹围、股骨长和头围的Z评分以及胎儿生长受限的差异没有统计学意义(P>0.05)。结论: 孕早期单纯TPOAb阳性略微增宽胎儿BPD, 但未见其影响其他生长指标, 该结果的可重复性与实际意义有待确定。

关键词: 甲状腺过氧化物酶抗体, 妊娠初期, 胎儿发育, 甲状腺疾病

Abstract:

Objective: To investigate the association of isolated thyroid peroxidase antibody (TPOAb) positive in the first trimester with fetal growth. Methods: A total of 16 446 pregnant women were included in the birth cohort study, whose last menstrual period was between May 2016 and April 2019 and with singleton pregnancy. Maternal serum samples were collected when they firstly came for prenatal care in the first trimester. The pregnant women were consecutively seen and followed in the hospital and the information of pregnant women was extracted from the electronic medical information system. The pregnant women were divided into isolated TPOAb positive group (n=1 654) and euthyroid group (n=14 792). Three fetal ultrasound examinations were scheduled during the routine prenatal visits at the hospital and were performed by trained sonographers. All fetal growth indicators were quantified as gestational age- and gender- adjusted standard deviation score (Z-score) using the generalized additive models for location, scale and shape (GAMLSS). Fetal growth indicators included estimated fetal weight (EFW), abdominal circumference (AC), biparietal diameter (BPD), femur length (FL) and head circumference (HC). Fetal growth restriction (FGR) was defined as AC or EFW Z-score<3rd centile based on clinical consensus. Generalized estimating equation (GEE) analysis was applied to assess the association of maternal isolated TPOAb positive with fetal growth. The generalized linear model was further used to analyze the association between isolated TPOAb positive and fetal growth indicator at different gestational ages when the fetal growth indicator was significantly associated with isolated TPOAb positive in the GEE mo-del. Results: The median gestational age at three ultrasound measurements was 23.6 (23.3, 24.1), 30.3 (29.7, 30.9), 37.3 (37.0, 37.7) weeks, respectively. The BPD Z-score was higher in isolated TPOAb positive women, compared with the euthyroid pregnant women after adjustment (β=0.057, 95%CI: 0.014-0.100, P=0.009). The generalized linear model showed the BPD Z-score was higher in the isolated TPOAb positive women at the end of 21-25 weeks (β=0.052, 95%CI: 0.001-0.103, P=0.044), 29-32 weeks (β=0.055, 95%CI: 0.004-0.107, P=0.035) and 36-40 weeks (β=0.068, 95%CI: 0.011-0.125, P=0.020), compared with the euthyroid pregnant women. There was no difference in other fetal growth indicators (EFW, AC, FL and HC) and FGR between the isolated TPOAb positive and euthyroid pregnant women. Conclusion: The BPD Z-score was slightly increased in the isolated TPOAb positive pregnant women in the first trimester, while other fetal growth indicators were not changed. The reproducibility and practical significance of this result need to be confirmed.

Key words: Thyroid peroxidase antibody, Pregnancy trimester, first, Fetal development, Thyroid di-seases

中图分类号: 

  • R714.256

表1

单纯TPOAb阳性孕妇与甲状腺功能正常孕妇的一般特征"

Items Isolated TPOAb positive (n=1 654) Euthyroid(n=14 792) P value
Maternal age/years 29.6 (27.2, 32.6) 29.4 (27.1, 32.2) 0.021
Maternal education levels 0.005
    Low (high school and below) 232 (14.0) 2 299 (15.5)
    Middle (vocational college) 670 (40.5) 6 378 (43.1)
    High (university and above) 752 (45.5) 6 115 (41.3)
Current employment status 0.115
    Yes 1 479 (89.4) 13 027 (88.1)
    No 175 (10.6) 1 765 (11.9)
Parity 0.918
    Primipara 925 (55.9) 8 297 (56.1)
    Multipara 729 (44.1) 6 495 (43.9)
Pre-pregnancy BMI 0.637
    Underweight 165 (10.0) 1 443 (9.8)
    Normal weight 1 052 (63.6) 9 599 (64.9)
    Overweight 348 (21.0) 2 928 (19.8)
    Obesity 89 (5.4) 822 (5.6)
Gestational age at thyroid function testing/weeks 9.0 (8.0, 10.1) 9.0 (8.0, 10.3) 0.623
TSH/(mIU/L) 1.1 (0.7, 1.6) 0.9 (0.5, 1.3) < 0.001
FT4/(pmol/L) 13.5 (12.5, 14.7) 13.6 (12.7, 14.8) < 0.001

表2

单纯TPOAb阳性孕妇与甲状腺功能正常孕妇在孕期的胎儿生长情况"

Items 21-25 weeks 29-32 weeks 36-40 weeks
Euthyroid
(n=14 285)
Isolated TPOAb positive
(n=1 606)
Euthyroid
(n=14 037)
Isolated TPOAb positive
(n=1 569)
Euthyroid
(n=11 466)
Isolated TPOAb positive
(n=1 273)
EFW/g 614.79±68.02 614.98±66.39 1529.19±181.38 1531.23±183.37 2935.17±305.42 2949.79±318.00
    Z-score -0.14±0.99 -0.13±0.98 0.00±0.99 0.00±0.99 -0.04±0.98 -0.01±1.00
AC/cm 19.07±0.92 19.08±0.92 26.11±1.27 26.14±1.28 33.04±1.54 33.10±1.59
    Z-score -0.02±0.98 0.00±0.99 -0.01±0.99 0.00±0.99 -0.03±0.98 0.00±1.00
BPD/cm 5.80±0.29 5.82±0.29 7.74±0.33 7.76±0.34 9.14±0.32 9.16±0.32
    Z-score -0.02±0.99 0.03±0.99 -0.01±0.99 0.05±1.00 -0.03±0.98 0.04±0.99
FL/cm 4.13±0.19 4.13±0.19 5.65±0.23 5.64±0.24 6.86±0.22 6.86±0.23
    Z-score -0.02±0.99 -0.03±0.98 0.00±0.99 -0.06±0.99 -0.02±0.98 -0.03±1.00
HC/cm 21.45±0.86 21.44±0.87 28.07±1.01 28.12±1.05 32.46±1.03 32.54±1.04
    Z-score -0.02±0.99 -0.01±0.99 -0.01±0.98 0.04±0.99 -0.03±0.98 0.04±0.99
FGR/% 607 (4.3) 62 (3.9) 535 (3.8) 57 (3.6) 407 (3.6) 52 (4.1)

表3

单纯TPOAb阳性与胎儿生长的关联分析"

ItemsAdjust model 1 Adjusted model 2
β or RR (95%CI) P value β or RR (95%CI) P value
EFW 0.007 (-0.036, 0.049) 0.760 0.012 (-0.031, 0.055) 0.590
AC 0.016 (-0.025, 0.057) 0.451 0.020 (-0.022, 0.061) 0.349
BPD 0.054 (0.011, 0.097) 0.013 0.057 (0.014, 0.100) 0.009
FL -0.026 (-0.068, 0.016) 0.224 -0.020 (-0.062, 0.023) 0.358
HC 0.028 (-0.013, 0.070) 0.183 0.031 (-0.011, 0.073) 0.148
FGR 1.02 (0.85, 1.21) 0.862 1.01 (0.84, 1.21) 0.922

表4

单纯TPOAb阳性与不同孕周BPD的Z评分的关联分析"

ItemsAdjust model 1 Adjusted model 2
β (95%CI) P value β (95%CI) P value
21-25 weeks 0.049 (-0.001, 0.100) 0.056 0.052 (0.001, 0.103) 0.044
29-32 weeks 0.049 (-0.002, 0.100) 0.060 0.055 (0.004, 0.107) 0.035
36-40 weeks 0.066 (0.010, 0.123) 0.022 0.068 (0.011, 0.125) 0.020
1 Dhillon-Smith RK , Coomarasamy A . TPO antibody positivity and adverse pregnancy outcomes[J]. Best Pract Res Clin Endocrinol Metab, 2020, 34 (4): 101433.
doi: 10.1016/j.beem.2020.101433
2 张思辰, 王少为, 赵晓东, 等. 妊娠期单纯甲状腺过氧化物酶抗体阳性妇女的妊娠结局及干预措施对妊娠结局影响的荟萃分析[J]. 中华妇产科杂志, 2016, 51 (4): 250- 257.
3 Springer D , Jiskra J , Limanova Z , et al. Thyroid in pregnancy: From physiology to screening[J]. Crit Rev Clin Lab Sci, 2017, 54 (2): 102- 116.
doi: 10.1080/10408363.2016.1269309
4 Huget-Penner S , Feig DS . Maternal thyroid disease and its effects on the fetus and perinatal outcomes[J]. Prenat Diagn, 2020, 40 (9): 1077- 1084.
doi: 10.1002/pd.5684
5 Zhang Y , Wang H , Pan X , et al. Patients with subclinical hypo-thyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis[J]. PLoS One, 2017, 12 (4): e175708.
6 Maraka S , Ospina NMS , O'Keeffe DT , et al. Subclinical hypothyroidism in pregnancy: A systematic review and meta-analysis[J]. Thyroid, 2016, 26 (4): 580- 590.
doi: 10.1089/thy.2015.0418
7 Thompson W , Russell G , Baragwanath G , et al. Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis[J]. Clin Endocrinol, 2018, 88 (4): 575- 584.
doi: 10.1111/cen.13550
8 Green LR , Hanson MA . Fetal and neonatal physiology[M]. 4th ed Philadelphia: Elsevier, 2011, 798
9 Alkandari F , Ellahi A , Aucott L , et al. Fetal ultrasound measurements and associations with postnatal outcomes in infancy and childhood: A systematic review of an emerging literature[J]. J Epidemiol Community Health, 2014, 69 (1): 41- 48.
10 Fulceri F , Guzzetta A , Athanasiadou A , et al. Antenatal ultrasound value in risk calculation for autism spectrum disorder: A systematic review to support future research[J]. Neurosci Biobehav Rev, 2018, 92, 83- 92.
doi: 10.1016/j.neubiorev.2018.05.016
11 Partap U , Sovio U , Smith GCS . Fetal growth and the risk of spontaneous preterm birth in a prospective cohort study of Nulliparous women[J]. Am J Epidemiol, 2016, 184 (2): 110- 119.
doi: 10.1093/aje/kwv345
12 Abel KM , Dalman C , Svensson AC , et al. Deviance in fetal growth and risk of autism spectrum disorder[J]. Am J Psychiatry, 2013, 170 (4): 391- 398.
doi: 10.1176/appi.ajp.2012.12040543
13 Zhang Y , Zhang C , Yang X , et al. Association of maternal thyroid function and thyroidal response to human chorionic gonadotropin with early fetal growth[J]. Thyroid, 2019, 29 (4): 586- 594.
doi: 10.1089/thy.2018.0556
14 Johns LE , Ferguson KK , Cantonwine DE , et al. Subclinical changes in maternal thyroid function parameters in pregnancy and fetal growth[J]. J Clin Endocrinol Metab, 2018, 103 (4): 1349- 1358.
doi: 10.1210/jc.2017-01698
15 van Mil NH , Steegers-Theunissen RPM , Bongers-Schokking JJ , et al. Maternal hypothyroxinemia during pregnancy and growth of the fetal and infant head[J]. Reprod Sci, 2012, 19 (12): 1315- 1322.
doi: 10.1177/1933719112450338
16 La'Ulu SL , Slev PR , Roberts WL . Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays[J]. Clin Chim Acta, 2007, 376 (1/2): 88- 95.
17 中华医学会内分泌学分会, 中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华围产医学杂志, 2012, 15 (7): 385- 403.
18 中华医学会妇产科学分会产科学组. 孕前和孕期保健指南(2018)[J]. 中华围产医学杂志, 2018, 21 (3): 145- 152.
19 Hadlock FP , Harrist RB , Sharman RS , et al. Estimation of fetal weight with the use of head, body, and femur measurements: A prospective study[J]. Am J Obstet Gynecol, 1985, 151 (3): 333- 337.
doi: 10.1016/0002-9378(85)90298-4
20 Rigby RA , Stasinopoulos DM . Generalized additive models for location, scale and shape[J]. Appl Statist, 2005, 54 (3): 507- 554.
21 Gordijn SJ , Beune IM , Thilaganathan B , et al. Consensus definition of fetal growth restriction: A Delphi procedure[J]. Ultrasound Obstet Gynecol, 2016, 48 (3): 333- 339.
doi: 10.1002/uog.15884
22 中国肥胖问题工作组数据汇总分析协作组. 我国成人体重指数和腰围对相关疾病危险因素异常的预测价值: 适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志, 2002, 23 (1): 5- 10.
23 Ghassabian A , Bongers-Schokking JJ , de Rijke YB , et al. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: The generation R study[J]. Thyroid, 2012, 22 (2): 178- 186.
doi: 10.1089/thy.2011.0318
24 Li Y , Shan Z , Teng W , et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months[J]. Clin Endocrinol (Oxf), 2010, 72 (6): 825- 829.
25 Brown AS , Surcel H , Hinkka-Yli-Salomäki S , et al. Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2015, (57): 86- 92.
26 Villar J , Gunier RB , Tshivuila-Matala COO , et al. Fetal cranial growth trajectories are associated with growth and neurodevelopment at 2 years of age: INTERBIO-21st fetal study[J]. Nat Med, 2021, 27 (4): 647- 652.
doi: 10.1038/s41591-021-01280-2
27 Henrichs J , Schenk JJ , Schmidt HG , et al. Fetal size in mid- and late pregnancy is related to infant alertness: The generation R study[J]. Dev Psychobiol, 2009, 51 (2): 119- 130.
doi: 10.1002/dev.20351
28 Thorpe-Beeston JG , Nicolaides KH , Felton CV , et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus[J]. N Engl J Med, 1991, 324 (8): 532- 536.
doi: 10.1056/NEJM199102213240805
29 Korevaar TIM , Steegers EAP , Pop VJ , et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: Two population-based prospective cohort studies[J]. J Clin Endocrinol Metab, 2016, 102 (1): 69- 77.
30 Abel MH , Caspersen IH , Sengpiel V , et al. Insufficient maternal iodine intake is associated with subfecundity, reduced foetal growth, and adverse pregnancy outcomes in the Norwegian mother, father and child cohort study[J]. BMC Med, 2020, 18 (1): 211.
doi: 10.1186/s12916-020-01676-w
31 Chen R , Li Q , Cui W , et al. Maternal iodine insufficiency and excess are associated with adverse effects on fetal growth: A prospective cohort study in Wuhan, China[J]. J Nutr, 2018, 148 (11): 1814- 1820.
doi: 10.1093/jn/nxy182
32 李阳桦, 张静波, 韩玉梅, 等. 2009—2013年北京市成年女性尿碘水平与甲状腺结节检出情况分析[J]. 中国预防医学杂志, 2015, 16 (6): 410- 413.
33 李阳桦, 任海林, 王全意, 等. 2012年北京市居民碘营养状况与食盐供碘量关系的初步分析[J]. 中华地方病学杂志, 2014, 33 (5): 537- 539.
[1] 董文红, 赵洁, 赵佳夕, 徐琳琳, 许雅君, . 外源性核苷酸对酒精发育毒性的拮抗作用[J]. 北京大学学报(医学版), 2012, 44(3): 426-430.
[2] 董颖, 张爽, 王美玲, 郭华, 张莹, 王颖, 李挺. 水泡状胎块及相关异常妊娠孕早期胎盘组织的病理特点[J]. 北京大学学报(医学版), 2011, 43(2): 194-198.
[3] 蒋文跃, 韩巍, 李志新. 成人疾病胎源说的证据及机制[J]. 北京大学学报(医学版), 2007, 39(1): 96-100.
[4] 张玉芳, 王海宁, 洪天配. ghrelin在甲状腺疾病组织中的表达[J]. 北京大学学报(医学版), 2006, 38(2): 193-196.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!